• Mianserin HCl: Mechanism and Research Uses

  2026-09-07

  Mianserin HCl is a tetracyclic antidepressant research compound and 5-HT2 receptor antagonist used to study serotonin receptor signaling pathway modulation. Historical clinical data show antidepressant efficacy comparable to amitriptyline with fewer reported side effects, while product-dossier data support additional cyclodextrin and antipathogenic research applications.

• U 46619 Workflows for Platelet and Vascular Research

  2026-09-07

  U 46619 provides a concentration-resolved TP-receptor challenge for connecting platelet shape change, signaling, secretion, and aggregation. This guide translates its defined response profile into practical platelet, vascular, renal, and blood-pressure workflows, with optimization strategies for reproducible results.

• DAPT (GSI-IX) in Notch Assay Design

  2026-09-05

  DAPT (GSI-IX) is more than a γ-secretase inhibitor: it is a timing-sensitive perturbation tool for separating Notch-dependent cell fate decisions from broader substrate effects. This article applies DAPT to FOXN1-driven thymic epithelial cell programming and translates recent developmental biology into practical assay design.

• EDC.HCl Coupling Workflow Guide

  2026-09-04

  EDC.HCl is a water-soluble carbodiimide used to activate carboxyl groups for amide bond formation with primary amines in peptide synthesis, bioconjugation, and related in vitro workflows. This guide covers handling, solution preparation, coupling controls, and troubleshooting; the reagent is not supported for in vivo or clinical use.

• Melatonin Blocks RIPK3 Necroptosis in Atrazine Kidney Injury

  2026-09-04

  The reference study identifies RIPK3-dependent necroptosis as a central mechanism of atrazine-induced renal tubular injury and shows that melatonin suppresses this pathway in cellular and animal models. Its combination of pathway analysis, RIPK3 knockdown, and molecular modeling provides a mechanistic framework for studying chemically induced nephrotoxicity beyond nonspecific oxidative stress.

• ANXA7, TIA1, and Retrograde Axonal RNA Transport

  2026-09-03

  The reference study identifies Annexin A7 as a calcium-sensitive facilitator of dynein-dependent retrograde transport for TIA1-containing ribonucleoprotein granules. Its findings connect failed axonal trafficking with pathological TIA1 aggregation, axonopathy, and neurodegeneration, providing a mechanistic framework for studying RNA-binding protein quality control in neurons.

• PBS (Phosphate-Buffered Saline): Lab Guide

  2026-09-03

  PBS (Phosphate-Buffered Saline), SKU K2818, is a sterile, ready-to-use isotonic buffer for cell washing, dilution, and selected in vitro assay workflows requiring controlled pH and salt conditions. It is intended for scientific research use only and should not be used for diagnostic, medical, or in vivo applications.

• CA-074 Me: A Causal Probe of Lysosomal Death

  2026-09-02

  CA-074 Me is a membrane-permeable cathepsin B inhibitor for resolving how lysosomal protease release contributes to necroptosis, apoptosis, and inflammation. This guide focuses on experimental interpretation, showing how to distinguish lysosomal membrane permeabilization from downstream cathepsin B-dependent cell death.

• Gramine, Ferroptosis, and the CUL3–MTDH Axis

  2026-09-02

  The reference study identifies Gramine as a candidate ferroptosis inducer that suppresses triple-negative breast cancer through a CUL3–MTDH regulatory axis. Its integrated binding, cellular, rescue, knockdown, and xenograft experiments provide a mechanistic framework for evaluating Gramine in ferroptosis-focused cancer biology research.

• Cannabidiol in Orofacial Inflammatory Pain

  2026-09-01

  A 2026 Brain Research Bulletin study shows that cannabidiol (CBD) can reduce acute orofacial inflammatory pain while also improving affective and cognitive abnormalities in chronic pain models. Its value lies in connecting peripheral inflammatory control, central endocannabinoid signaling, and serotonin dynamics rather than treating nociception as an isolated endpoint.

• Necrosulfonamide: Selective MLKL Inhibitor

  2026-09-01

  Necrosulfonamide (NSA) is a selective MLKL inhibitor for mechanistic necroptosis assays. It blocks phosphorylated MLKL membrane translocation without preventing MLKL phosphorylation, with a reported approximately 124 nM IC50 in HT-29 cells under the product-described assay conditions.

• 6C Culture Extends Mouse Corneal Epithelial Proliferation

  2026-08-31

  An et al. developed a serum-free, feeder-free 6C culture system that preserves mouse corneal epithelial proliferative activity by combining six pathway modulators in an air-lifted format. The approach reduced epithelial–mesenchymal transition-associated changes, maintained progenitor markers, and improved the supply of cells for corneal wound-healing and regenerative medicine studies.

• H62 Dual Tubulin–DNMT Inhibition in Leukemia

  2026-08-31

  The reference study identifies H62, a letermovir derivative, as a leukemia-active compound with complementary activity against β-tubulin and DNMT1. By combining cell-based, molecular, transcriptomic, and Friend virus–induced erythroleukemia experiments, the work connects microtubule disruption with epigenetic reprogramming and provides a framework for evaluating dual-mechanism leukemia model compounds.

• AP1903 for Controlled FKBP Activation

  2026-08-30

  AP1903 converts FKBP fusion-protein design into a tunable system for controlled protein activation, apoptosis pathway research, and conditional cell ablation. Pairing ligand-induced dimerization with Kozak-based expression libraries can separate protein-abundance effects from activation effects in scalable assays.

• Ajugol, Mitophagy, and Chondrocyte Pyroptosis

  2026-08-29

  The reference study identifies impaired PINK1/Parkin-dependent mitophagy as a mechanistic link between PI3K/AKT/mTOR signaling and chondrocyte pyroptosis in acute gouty arthritis. By combining computational analysis with cell and mouse experiments, it shows that ajugol protects cartilage partly by restoring mitochondrial quality control rather than simply suppressing inflammatory mediators.

8569 records 5/572 page Previous Next 12345 下5页 Last page